In addition to inflammatory factors, nutritional indicators can also predict the prognosis of breast cancer, and pre-therapy serum albumin has been used as a predictor to assess disease progression, disease severity and prognosis (Yeun & Kaysen, 1998; Gupta & Lis, 2010). Here, ALB is linked to breast carcinoma.